10 results on '"Eskandari-Roozbahani, N."'
Search Results
2. Zataria multiflora Boiss. essential oil against ethanol-induced gastric ulcer in rats by antioxidant properties and increase in nitric oxide production
- Author
-
Shomali, T., mahdi raeesi, and Eskandari-Roozbahani, N.
- Subjects
Medicine (General) ,R5-920 ,Gastric ulcer ,Rat ,Nitric oxide ,Zataria multiflora Boiss ,Therapeutics. Pharmacology ,RM1-950 ,Antioxidant ,Essential oil - Abstract
Introduction: The present study investigated protective effect of Zataria multiflora essential oil on ethanol-induced gastric ulcer in rats along with its possible mechanism(s). Methods: Eighty male adult rats were randomly allocated into 8 groups as follows: 1: negative control (NC); 2, 3 and 4: positive control (PC, distilled water), vehicle control (VC, corn oil) and comparative control (CC, omeprazole 20 mg/kg in distilled water), respectively; 5, 6, 7 and 8: treated with 100, 200, 400 and 800 μL/kg Z. multiflora essential oil. After 1 hour, gastric ulcer was induced by 4 mL/kg 75% ethanol orally to rats of groups 2-8. One hour later, blood samples were collected and then all rats were sacrificed and their stomachs were immediately removed. Results: In PC and VC groups severe lesions were observed in stomachs where mucosal lesions in CC group as well as groups treated with Z. multiflora essential oil (especially higher doses) were very mild with regard to ulcer area and number. No significant difference was observed in mucosal prostaglandin E2 (PGE2) and serum tumor necrosis factor-α (TNF-α) level among groups, gastric mucosal nitric oxide (NO) content was significantly higher in rats treated with Z. multiflora essential oil at 200, 400 and 800 μL/kg as compared to PC group. Rats in CC, Z. multiflora 400 and Z. multiflora 800 groups showed higher mucosal total antioxidant capacity (TAC) as compared to PC group. Conclusion: Z. multiflora essential oil has a gastro-protective effect against ethanol-induced gastric ulcer in rats which is probably due to its antioxidant and NO production enhancing effect.
- Published
- 2016
3. A Novel Anticoagulation Method Based on Electrochemical Characteristics of Blood: An in vitro Study.
- Author
-
Jahanbani A, Goodarzi M, Sajjadi Dezfouli SM, Yourdkhani MR, and Eskandari Roozbahani N
- Subjects
- Animals, Sheep, Renal Dialysis adverse effects, Blood Coagulation, Blood Coagulation Tests methods, Prothrombin Time, Partial Thromboplastin Time, Anticoagulants pharmacology, Thrombosis etiology
- Abstract
This in vitro experimental investigation aimed to provide a novel method for preventing blood clotting based on the electrochemical characteristics of blood. Using this method in cases such as dialysis can minimize the risk of blood clots and also avoid hemorrhagic risk for patients. Blood samples were collected from 13 sheep (45 kg) (25 mL), and the clotting time (CT) was measured using a 20-min cutoff after they were separated into control and experimental samples. The test blood sample was put in a cell designed with two aluminum electrodes (positive pole/anode) located in a container containing 0.9% sodium chloride (as a salt bridge) and a platinum (negative pole/cathode) linked to a power supply (-3.5 V, 1 mA/cm2). Biochemical and hematological tests to check blood damage and clotting were performed. The control sample coagulated after 8 min, while the electrified blood did not, even at the end of the cutoff time. Among hematologic and biochemical tests, the average time of prothrombin time (PT) and partial thromboplastin time (PTT) was significantly different between the control and test samples (p = 0.001). Our findings on electrified blood with expanding CT, PT, and PTT times revealed that the electric current passing through the blood enhanced the CT. Furthermore, no change in biochemical or hematological factors demonstrated that this current had no detrimental effect on the blood., (© 2022 S. Karger AG, Basel.)
- Published
- 2023
- Full Text
- View/download PDF
4. Clinical Characteristics and Risk Factors of COVID-19 in 60 Adult Cancer Patients.
- Author
-
Aznab M, Eskandari Roozbahani N, and Moazen H
- Abstract
Background: During the pandemic of COVID-19, cancer patients have been considered as one high-risk group in the morbidity and mortality of COVID-19. This study aimed to describe the clinical symptoms and risk factors of COVID-19 in cancer patients., Method: In a prospective cross-sectional study, during a year, all cancer patients who underwent chemotherapy and/or targeted therapy in our clinic (Kermanshah, Iran) were followed up in terms of getting COVID-19. We analyzed the effect of tumor features and demographic information on clinical manifestations, survival status, therapeutic outcomes, and severity of the disease COVID-19 in 2 categories of cancer (hematologic and solid cancers)., Results: Most of the patients (68%) were in the solid tumor category, including breast cancer (24.4%), colon cancer (22%), and gastric cancer (9.8%). There was a statistically significant difference between 2 categories of cancer in the clinical manifestations: the stage of cancer and survival status ( P < .05). Logistic regression analysis showed that the risk of death in cancer patients with COVID-19 along with symptoms of diarrhea (odds ratio [OR] = 12.8, P = .004), the difficulty of breath (OR = 10.73, P = .034), drop of SO2 (OR = 1.334, P = .003), thrombocytopenia (OR = 1.022, P = .02), anemia (OR = 2.72, P = .011), requiring mechanical ventilation (OR = 9.24, P = .004), pleural infusion (OR = 10.28, P = .02), and intensive care unit (ICU) admission (OR = 7.389, P = .009) increases independent of other variables. The COVID-19 mortality rate in our cancer patients was 23%., Conclusions: Thrombocytopenia, anemia, and diarrhea are symptoms that, along with common symptoms such as lung involvement, difficulty breathing, and the need for a ventilator, increase the risk of death in cancer patients with COVID-19., Competing Interests: Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (© The Author(s) 2022.)
- Published
- 2022
- Full Text
- View/download PDF
5. Is there any association between migraine headache and polycystic ovary syndrome (PCOS)? A review article.
- Author
-
Sarahian N, Noroozzadeh M, Saei Ghare Naz M, Eskandari-Roozbahani N, Mahboobifard F, and Ramezani Tehrani F
- Subjects
- Biomarkers, Disease Management, Female, Hormones metabolism, Humans, Hypothalamo-Hypophyseal System metabolism, Migraine Disorders metabolism, Neurotransmitter Agents metabolism, Polycystic Ovary Syndrome metabolism, Disease Susceptibility, Migraine Disorders complications, Migraine Disorders etiology, Polycystic Ovary Syndrome complications, Polycystic Ovary Syndrome etiology
- Abstract
Background: Polycystic ovary syndrome (PCOS) and migraine headaches are considered to be common health problems that may share some risk factors. This study aimed to discuss the possible association between migraine headache and polycystic ovary syndrome., Methods and Results: In this narrative review, PubMed, Scopus, Web of Science, and Google Scholar were systematically searched for retrieving and summarizing published studies up to January 2021 to explore the possible interplay between migraine headache and PCOS. We discuss the possible pathways that may explain the association between migraine headaches and PCOS signs/symptoms and complications. While genetic factors have profound effects on the pathogenesis of migraine headaches, sex hormones, including estrogen and progesterone may also play an important role in inducing migraine headaches. Some disorders, such as sleep apnea, amenorrhea, and vascular disease that are more likely to occur in women with PCOS, may cause or exacerbate migraine headaches in women with PCOS., Conclusions: Future comprehensive studies are needed to investigate the exact underlining mechanisms related to the association between PCOS and migraine headaches., (© 2021. The Author(s), under exclusive licence to Springer Nature B.V.)
- Published
- 2022
- Full Text
- View/download PDF
6. Value of influenza vaccines in cancer patients during the coronavirus (COVID-19) pandemic: a cross-sectional study.
- Author
-
Aznab M, Eskandari Roozbahani N, and Moazen H
- Subjects
- Adolescent, Adult, Aged, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Pandemics, SARS-CoV-2, Vaccination, Young Adult, COVID-19, Influenza Vaccines, Neoplasms epidemiology
- Abstract
Background: According to the recommendation of the Centers for Disease Control and Prevention (CDC), getting influenza vaccines during the coronavirus (COVID-19) pandemics is especially important for people with certain underlying medical conditions, like cancer. Due to the similarities between the symptoms of influenza and COVID-19, receiving the flu vaccine in suspicious cases can be helpful because it will make it easier to request a medical test and diagnosis. In this study, the value of influenza vaccination in the cancer population was investigated., Methods: In a cross-sectional study, all cancer patients who were referred to our clinic and had eligibility to receive the flu vaccine were included in our study for following up clinical signs every week for one month. All patients who were vaccinated from October 1 to November 15, 2020 were investigated. The most side effects that were followed were fever, runny nose, bone pain, and life-threatening or persistent adverse effects., Results: From a total of 288 patients (median age: 52 years (range 18-79), 112 (38.9%) males and 176 (61.1%) female) with different types of cancers, only two patients had an adverse effect of vaccination (including bone pain, runny nose, and fatigue), and one had COVID-19 ten days after vaccination. The rest of the patients did not show any side effects due to flu vaccination after one month of follow-up. Cancer patients are recommended to receive the flu vaccine annually during the pandemic and after the end of this pandemic, usually during the flu epidemic season to reduce mortality., (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2021
- Full Text
- View/download PDF
7. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
- Author
-
Sarahian N, Sarvazad H, Sajadi E, Rahnejat N, and Eskandari Roozbahani N
- Subjects
- Female, Humans, Risk Factors, Alzheimer Disease epidemiology, Alzheimer Disease etiology, Anovulation, Hyperandrogenism, Insulin Resistance, Polycystic Ovary Syndrome complications
- Abstract
Background: The most common endocrine and metabolic disorders in premenopausal women is polycystic ovary syndrome (PCOS), characterized by hyperandrogenism, chronic anovulation, and/or ultrasound evidence of small ovarian cysts. Obesity and insulin resistance are also the main factors influencing the clinical manifestations of this syndrome. Alzheimer's disease (AD) is the most typical progressive neurodegenerative disorder of the brain, and recent studies suggest a relationship between endocrinal dysregulation and neuronal loss during AD pathology., Aim: This study aimed to evaluate the common risk factors for Alzheimer's and PCOS based on previous studies. Knowing the common risk factors and eliminating them may prevent neurodegenerative Alzheimer's disease in the future., Method: In this narrative review, international databases, including Google Scholar, Scopus, PubMed, and the Web of Science, were searched to retrieve the relevant studies. The relevant studies' summaries were categorized to discuss the possible pathways that may explain the association between Alzheimer's and PCOS signs/symptoms and complications., Results: According to our research, the factors involved in Alzheimer's and PCOS disorders may share some common risk factors. In patients with PCOS, increased LH to FSH ratio, decreased vitamin D, insulin resistance, and obesity are some of the most important factors that may increase the risk of Alzheimer's disease., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
8. The Cataleptic, Asymmetric, Analgesic, and Brain Biochemical Effects of Parkinson's Disease Can Be Affected by Toxoplasma gondii Infection.
- Author
-
Taherianfard M, Riyahi M, Razavi M, Bavandi Z, Eskandari Roozbahani N, and Namavari MM
- Subjects
- Animals, Brain Chemistry, Catalepsy physiopathology, Corpus Striatum cytology, Corpus Striatum metabolism, Corpus Striatum parasitology, Corpus Striatum pathology, Disease Models, Animal, Dopamine metabolism, Male, Neurons cytology, Nociception physiology, Rats, Rats, Sprague-Dawley, Behavior, Animal physiology, Parkinson Disease metabolism, Parkinson Disease parasitology, Parkinson Disease physiopathology, Toxoplasmosis metabolism, Toxoplasmosis physiopathology
- Abstract
Purpose: Parkinson's disease (PD) is a neurodegenerative disorder with progressive motor defects. Therefore, the aim of the present investigation was to examine whether catalepsy, asymmetry, and nociceptive behaviors; the Nissl-body and neuron distribution; brain-derived neurotrophic factor (BDNF); malondialdehyde (MDA); total antioxidant capacity (TAC) levels; and the percentage of dopamine depletion of striatal neurons in the rat model of Parkinson's disease (PD) can be affected by Toxoplasma gondii (TG) infection., Methods: Fifty rats were divided into five groups: control (intact rats), sham (rats which received an intrastriatal injection of artificial cerebrospinal fluid (ACSF)), PD control (induction of PD without TG infection), TG control (rats infected by TG without PD induction), and PD infected (third week after PD induction, infection by TG was done). PD was induced by the unilateral intrastriatal microinjection of 6-hydroxydopamine (6-OHDA) and ELISA quantified dopamine, BDNF, MDA, and TAC in the striatum tissue. Cataleptic, asymmetrical, nociceptive, and histological alterations were determined by bar test, elevated body swing test, formalin test, and Nissl-body and neuron counting in the striatal neurons., Results: The results demonstrated that PD could significantly increase the number of biased swings, descent latency time, and nociceptive behavior and decrease the distribution of Nissl-stained neurons compared to the control and sham groups. TG infection significantly improved biased swing, descent latency time, nociceptive behavior, and the Nissl-body distribution in striatal neurons in comparison to the PD control group. The striatal level of BDNF in the PD-infected and TG control groups significantly increased relative to the PD control group. The striatal MDA was significantly higher in the PD control than other groups, while striatal TAC was significantly lower in the PD control than other groups., Conclusions: The current study indicates that TG infection could improve the cataleptic, asymmetric, nociceptive and behaviors; the level of striatal dopamine release; BDNF levels; TAC; and MDA in PD rats., Competing Interests: The authors declare that they have no conflicts of interest., (Copyright © 2020 Mahnaz Taherianfard et al.)
- Published
- 2020
- Full Text
- View/download PDF
9. Gastro-protective effect of Biebersteinia multifida root hydro-methanolic extract in rats with ethanol-induced peptic ulcer.
- Author
-
Raeesi M, Eskandari-Roozbahani N, and Shomali T
- Abstract
Objective: Biebersteinia multifida is one of the native plants of Iran and its root is used in folk medicine. This study aimed to evaluate the gastro-protective effect of the hydro-methanolic extract of this plant's roots against ethanol-induced gastric ulcer in rats., Materials and Methods: The following five groups of seven rats were included in this study: control (C), gastric ulcer (GU), control omeprazole (CO) and two treatment groups (the latter 3 groups were rats with gastric ulcer that orally received omeprazole, 20 mg/kg, or the root extract at 150 and 300 mg/kg (BM 150 and BM 300, respectively) 1 hour before ulcer induction). One hour after ulcer induction, blood sampling was performed and after sacrificing animals, the stomachs were immediately removed. Gastric mucosal injury was studied grossly to determine the number and area of gastric ulcers. The level of nitric oxide (NO) and total antioxidant capacity (TAC) in gastric mucosa as well as serum TNF-α were determined., Results: In GU group, severe mucosal injuries were observed (p<0.0001 as compared to C group). The lesions in CO and treatment groups were much milder than GU group by regarding ulcer area and number (p<0.001 for all cases). In treated (BM 150 and BM 300) groups, the gastric mucosal TAC and NO level were significantly higher than GU group (p<0.05 for all cases). Serum TNF-α level was not significantly different between GU and other groups., Conclusion: B. multifida possesses gastro-protective effects against ethanol-induced ulcer model; this effect is at least partly related to plant's antioxidant and NO production accelerating properties., Competing Interests: The authors declare that there is no conflict of interest.
- Published
- 2019
10. Neuroprotective Effect of Zataria Multiflora Essential Oil on Rats With Alzheimer Disease: A Mechanistic Study.
- Author
-
Eskandari-Roozbahani N, Shomali T, and Taherianfard M
- Abstract
Introduction: Finding herbs with promising effects to prevent or postpone Alzheimer Disease (AD) is highly demanded. The present study aimed at clarifying plausible effects and related mechanism(s) of Zataria Multiflora Essential Oil (ZMEO) against memory impairment in a rat model of the AD., Methods: Forty male adult rats were categorized into four groups and treated as follows: 1. The Negative Control (NC): no treatment; 2. Sham control (sham): distilled water by Intracerebroventricular (ICV) injection; 3. The AD control (AD): Aβ 1-42 by ICV injection; and 4. The ZMEO group: Aβ 1-42 by ICV injection and ZMEO at 100 μL/kg/d orally for 20 days., Results: After Congo red staining of the hippocampus, a relative decrease in amyloid deposits was observed in the ZMEO group. Moreover, rats showed better outcomes in Morris Water Maze (MWM) test, reduced hippocampal acetylcholinesterase (AchE) activity, and higher Brain-Derived Neurotrophic Factor (BDNF) content as compared with the AD group (P<0.05). However, no significant changes in antioxidant status was observed (P>0.05)., Conclusion: ZMEO has a protective effect against memory impairment in rats with AD at least partly via reducing hippocampal AchE activity and enhancement of BDNF levels without a change in antioxidant status. These findings can pave the way for future studies on the usefulness of this herb in AD prevention., Competing Interests: Conflict of interest Authors declared no conflict of interest.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.